Literature DB >> 10583327

Pseudo-reticulocytosis as a result of malaria parasites.

J J Hoffmann1, J M Pennings.   

Abstract

Recently fully automated methods for enumerating reticulocytes have become available as an integral function in routine haematology analysers. In such methods, all intraerythrocytic nucleic acid is stained and can be regarded as representing reticulocytes. It has previously been shown that Howell-Jolly bodies may be counted as reticulocytes in automated flow cytometric methods. In the present paper, data from two patients are described indicating that severe malaria infection may lead to falsely increased reticulocyte counts, at least in the CELL-DYN(R) 4000 haematology analyser. In this instrument, the intraerythrocytic nuclear material of the parasites will be stained and counted as reticulocytes. This phenomenon appears to be independent of the type of Plasmodium infection. Clinical haematology laboratories should be aware of this potential source of pseudo-reticulocytosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10583327     DOI: 10.1046/j.1365-2257.1999.00243.x

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN: 0141-9854


  3 in total

1.  Detection of imported malaria with the Cell-Dyn 4000 hematology analyzer.

Authors:  Peter C Wever; Yvonne M C Henskens; Piet A Kager; Jacob Dankert; Tom van Gool
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

Review 2.  Automated haematology analysis to diagnose malaria.

Authors:  Germán Campuzano-Zuluaga; Thomas Hänscheid; Martin P Grobusch
Journal:  Malar J       Date:  2010-11-30       Impact factor: 2.979

3.  Cytotoxic CD8+ T cells recognize and kill Plasmodium vivax-infected reticulocytes.

Authors:  Caroline Junqueira; Camila R R Barbosa; Pedro A C Costa; Andréa Teixeira-Carvalho; Guilherme Castro; Sumit Sen Santara; Rafael P Barbosa; Farokh Dotiwala; Dhelio B Pereira; Lis R Antonelli; Judy Lieberman; Ricardo T Gazzinelli
Journal:  Nat Med       Date:  2018-07-23       Impact factor: 53.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.